Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Mech Behav Biomed Mater ; 110: 103947, 2020 10.
Article in English | MEDLINE | ID: mdl-32957239

ABSTRACT

OBJECTIVES: The purpose of this study was to study the effects on Young's modulus and conversion degree of variations in polymerization conditions during the 3-point bending test of composite samples in accordance with the ISO 4049 standard. METHODS: Three nanocomposites were used in the 3-point bending test based on the conditions described in the ISO 4049 standard. Samples of 2 mm × 2 mm x 25 mm were fabricated and tested with a different number of irradiation points and irradiation time. Conversion degree of the samples were also measured by micro-Raman spectroscopy and correlated with the Young's modulus values obtained for each one. RESULTS: The variations in curing protocol during specimen's realization influenced the Young's modulus and degree of conversion of all composites. These two properties correlated well. The ISO 4049 standard defines the conditions for performing the properties tests of composites to allow reproducibility and comparison of different studies. Concerning the 3-point bending test, even a minimal change in the state causes differences in the results obtained. The standard should thus clarify the tools that can be used when producing samples in order to minimize discrepancies. SIGNIFICANCE: The influence of the parameters surrounding the design of the samples should be controlled and defined so as not to include bias in the studies carried out. This will allow literature studies to be compared with more accuracy.


Subject(s)
Composite Resins , Elastic Modulus , Materials Testing , Polymerization , Reproducibility of Results
2.
Anal Bioanal Chem ; 412(4): 949-962, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31853604

ABSTRACT

The literature is rich in proof of concept studies demonstrating the potential of Raman spectroscopy for disease diagnosis. However, few studies are conducted in a clinical context to demonstrate its applicability in current clinical practice and workflow. Indeed, this translational research remains far from the patient's bedside for several reasons. First, samples are often cultured cell lines. Second, they are prepared on non-standard substrates for clinical routine. Third, a unique supervised classification model is usually constructed using inadequate cross-validation strategy. Finally, the implemented models maximize classification accuracy without taking into account the clinician's needs. In this paper, we address these issues through a diagnosis problem in real clinical conditions, i.e., the diagnosis of chronic lymphocytic leukemia from fresh unstained blood smears spread on glass slides. From Raman data acquired in different experimental conditions, a repeated double cross-validation strategy was combined with different cross-validation approaches, a consensus label strategy and adaptive thresholds able to adapt to the clinician's needs. Combined with validation at the patient level, classification results were improved compared to traditional strategies.


Subject(s)
Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis , Spectrum Analysis, Raman/methods , Algorithms , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/blood , Supervised Machine Learning
3.
Analyst ; 142(8): 1333-1341, 2017 Apr 10.
Article in English | MEDLINE | ID: mdl-28352887

ABSTRACT

Spectroscopic markers characteristic of reference glycosaminoglycan molecules were identified previously based on their vibrational signatures. Infrared spectral signatures of glycosaminoglycans in fixed cells were also recently demonstrated but probing live cells still remains challenging. Raman microspectroscopy is potentially interesting to perform studies under physiological conditions. The aim of the present work was to identify the Raman spectral signatures of GAGs in fixed and live cells and in their conditioned media. Biochemical and Raman analyses were performed on five cell types: chondrocytes, dermal fibroblasts, melanoma (SK-MEL-28), wild type CHO, and glycosaminoglycan-defective mutant CHO-745 cells. The biochemical assay of sulfated GAGs in conditioned media was only possible for chondrocytes, dermal fibroblasts, and wild type CHO due to the detection limit of the test. In contrast, Raman microspectroscopy allowed probing total glycosaminoglycan content in conditioned media, fixed and live cells and the data were analysed by principal component analysis. Our results showed that the Raman technique is sensitive enough to identify spectral markers of glycosaminoglycans that were useful to characterise the conditioned media of the five cell types. The results were confirmed at the single cell level on both live and fixed cells with a good differentiation between the cell types. Furthermore, the principal component loadings revealed prominent glycosaminoglycan-related spectral information. Raman microspectroscopy allows monitoring of the glycosaminoglycan profiles of single live cells and could therefore be developed for cell screening purposes and holds promise for identifying glycosaminoglycan signatures as a marker of cancer progression in tissues.


Subject(s)
Chondrocytes/cytology , Culture Media, Conditioned/chemistry , Fibroblasts/cytology , Glycosaminoglycans/chemistry , Spectrum Analysis, Raman , Animals , CHO Cells , Cell Line, Tumor , Cricetinae , Cricetulus , Humans , Melanoma
4.
Faraday Discuss ; 187: 521-37, 2016 06 23.
Article in English | MEDLINE | ID: mdl-27048927

ABSTRACT

Several proof-of-concept studies on the vibrational spectroscopy of biofluids have demonstrated that the methodology has promising potential as a clinical diagnostic tool. However, these studies also show that there is a lack of a standardised protocol in sample handling and preparation prior to spectroscopic analysis. One of the most important sources of analytical errors is the pre-analytical phase. For the technique to be translated into clinics, it is clear that a very strict protocol needs to be established for such biological samples. This study focuses on some of the aspects of the pre-analytical phase in the development of the high-throughput Fourier Transform Infrared (FTIR) spectroscopy of some of the most common biofluids such as serum, plasma and bile. Pre-analytical considerations that can impact either the samples (solvents, anti-coagulants, freeze-thaw cycles…) and/or spectroscopic analysis (sample preparation such as drying, deposit methods, volumes, substrates, operators dependence…) and consequently the quality and the reproducibility of spectral data will be discussed in this report.


Subject(s)
Analytic Sample Preparation Methods/methods , Analytic Sample Preparation Methods/standards , Body Fluids/chemistry , Body Fluids/diagnostic imaging , Spectroscopy, Fourier Transform Infrared/methods , Spectroscopy, Fourier Transform Infrared/standards , Anticoagulants/chemistry , Bile/chemistry , Freezing , Humans , Plasma/chemistry , Reproducibility of Results , Serum/chemistry , Solvents/chemistry , Vibration
5.
Analyst ; 140(21): 7382-90, 2015 Nov 07.
Article in English | MEDLINE | ID: mdl-26413856

ABSTRACT

BACKGROUND AND OBJECTIVES: HydroxyEthyl Starch (HES) has been one of the most commonly used colloid volume expanders in intensive care units for over 50 years. The first and second generation HES, with a high molecular weight (≥200 kD) and a high degree of substitution (≥0.5), has been associated with both renal dysfunction and osmotic nephrosis-like lesions in histological studies. Recently, third generation HES (130 kD/<0.5) has also been shown to impair renal function in critically ill adult patients although tubular accumulation of HES has never been proven in the human kidney. Our objective was to demonstrate the potential of Raman micro-imaging to bring out the presence of third generation-HES in the kidney of patients having received the volume expander. DESIGN: Four biopsies presenting osmotic nephrosis-like lesions originated from HES-administrated patients with impaired renal function were compared with HES-negative biopsies (n = 10) by Raman microspectroscopy. RESULTS: The first step was dedicated to the identification of a specific vibration of HES permitting the detection of the cellular and tissue accumulation of the product. This specific vibration at 480 cm(-1) is assigned to a collective mode of the macromolecule; it is located in a spectral region with a limited contribution from biological materials. Based on this finding, HES distribution within tissue sections was investigated using Raman micro-imaging. Determination of HES positive pixels permitted us to clearly distinguish positive cases from HES-free biopsies (proportions of positive pixels from the total number of pixels: 23.48% ± 28 vs. 0.87% ± 1.2; p = 0.004). CONCLUSIONS: This study shows that Raman spectroscopy is a candidate technique to detect HES in kidney tissue samples currently manipulated in nephrology departments. In addition, on the clinical aspect, our approach suggests that renal impairment related to third generation HES administration is associated with osmotic nephrosis-like lesions and HES accumulation in the kidney.


Subject(s)
Hydroxyethyl Starch Derivatives/chemistry , Kidney Diseases/pathology , Nephrology/methods , Spectrum Analysis, Raman/methods , Acute Kidney Injury , Adult , Aged , Biopsy , Colloids/chemistry , Female , Humans , Hydroxyethyl Starch Derivatives/analysis , Kidney/pathology , Kidney Diseases/metabolism , Kidney Transplantation , Male , Middle Aged , Monocytes/cytology , Osmosis , Vibration
6.
Trends Biotechnol ; 32(5): 254-62, 2014 May.
Article in English | MEDLINE | ID: mdl-24703620

ABSTRACT

Vibrational spectroscopy using both infrared and Raman spectroscopies has been used in recent years with the aim to aid clinicians in disease diagnosis. More recently, these techniques have been applied to study stem cell differentiation and to determine stem cell presence in tissues. These studies have demonstrated the potential of these techniques in better characterising stem cell differentiation phenotypes with potential applications in tissue engineering strategies. However, before the translation of vibrational spectroscopy into clinical practice becomes a reality, several issues still need to be addressed. We describe here an overview of the work carried out so far and the problems that might be encountered when using vibrational spectroscopy.


Subject(s)
Cytological Techniques/methods , Spectrophotometry, Infrared/methods , Spectrum Analysis, Raman/methods , Stem Cells/physiology , Cell Differentiation , Humans , Stem Cells/chemistry
7.
Analyst ; 138(14): 4006-14, 2013 Jul 21.
Article in English | MEDLINE | ID: mdl-23608738

ABSTRACT

Hepatocellular carcinoma (HCC) is the third most common cause of cancer death worldwide. The development of novel diagnostic methods is needed to detect tumours at an early stage when patients are eligible for curative treatments. The purpose of this proof-of-concept study was to determine if micro-Raman spectroscopy applied to the sera of cirrhotic patients may be an alternative method for rapidly discriminating patients with and without HCC. Serum samples were collected from 2 groups of patients: cirrhotic patients with HCC (n = 37) and without HCC (n = 34). Two different approaches were used, dried serum drops and freeze-dried serum, and micro-Raman spectra were acquired in the point-mode with a 785 nm laser excitation in the spectral range of 600-1800 cm(-1). Spectra were quality-tested and pre-processed (smoothing, baseline subtraction, vector normalization). Using principal component analysis, the 2 classes, corresponding to cirrhotic patients with and without HCC, could not be differentiated. In contrast, the support vector machine method using the leave-one-out cross validation procedure was able to correctly classify the two groups of patients with an overall rate of accuracy of 84.5% to 90.2% for dried serum drops and 86% to 91.5% for freeze-dried serum. These results are promising and support the concept that serum micro-Raman spectroscopy may become a useful diagnostic tool to detect biomarkers in the field of cancer, as described here for distinguishing between cirrhotic patients with and without HCC.


Subject(s)
Biomarkers, Tumor/blood , Carcinoma, Hepatocellular/diagnosis , Liver Cirrhosis/diagnosis , Liver Neoplasms/diagnosis , Spectrum Analysis, Raman/methods , Aged , Carcinoma, Hepatocellular/blood , Carcinoma, Hepatocellular/etiology , Case-Control Studies , Female , Humans , Liver Cirrhosis/blood , Liver Cirrhosis/complications , Liver Neoplasms/blood , Liver Neoplasms/etiology , Male , Middle Aged , Principal Component Analysis , Sensitivity and Specificity , Support Vector Machine
SELECTION OF CITATIONS
SEARCH DETAIL
...